North America Soft Tissue Repair Market Anticipated to Develop With a CAGR of 6.05% Between 2021 and 2028 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "North America Soft Tissue Repair Market 2021-2028" report has been added to ResearchAndMarkets.com's offering.

The market for soft tissue repair in North America is anticipated to develop with a CAGR of 6.05% by revenue, during the forecast years 2021-2028. The United States and Canada together form the market in this region.

Canada is one of the world's most advanced countries. As a result, the government of the nation strongly focuses on healthcare and medical infrastructure. In 2019, the total healthcare expenditure in Canada was $264 billion, or $7,068 per person. Overall, healthcare spending represents nearly 11.6% of the national GDP. Therefore, there is a huge demand for soft tissue repair in the country.

Further, according to the government's estimates, more than 1.4 million people have heart disease. It is also one of the leading causes of death here, claiming over 33,600 lives every year. This is another factor driving the demand for soft tissue repair.

According to the Canadian Institute for Health Information, approximately 17,655 individuals were hospitalized for sports-related injuries during the period from 2016 to 2017. Though sports injuries are not as common as falls, they can still be quite serious. Moreover, according to Statistics Canada, there were 6,592,61 people aged 65 years and above present in the country as of July 2019, and this number is likely to rise in the coming years.

With the growing prevalence of musculoskeletal diseases, the rising elderly population, and a rise in the incidences of sports-related & other injuries, the demand for soft tissue repair is rising in Canada. This growing demand is helping the market to grow further in the coming years.

COMPETITIVE OUTLOOK

The dominant players in the soft tissue repair market are Bard Peripheral Vascular Inc, Becton Dickinson and Company (BD), Boston Scientific Corporation, Stryker Corporation, Athersys Inc, Allergan, Baxter International Inc, and Smith & Nephew Plc.

Key Topics Covered:

1. North America Soft Tissue Repair Market - Summary

2. Industry Outlook

2.1. Impact of Covid-19 on the Soft Tissue Repair Market

2.2. Key Insights

2.3. Porter's Five Forces Model

2.3.1. Threat of New Entrants

2.3.2. Threat of Substitute Products

2.3.3. Bargaining Power of Buyers

2.3.4. Bargaining Power of Suppliers

2.3.5. Competitive Rivalry

2.4. Market Attractiveness Index

2.5. Vendor Scorecard

2.6. Key Strategic Developments

2.6.1. Contracts and Partnerships

2.6.2. Business Expansions, Announcements, and Divestitures

2.6.3. Acquisitions & Mergers

2.6.4. New Product Launches & Developments

2.7. Market Drivers

2.7.1. Incidence of Soft Tissue-Associated Diseases Driving the Market Growth

2.7.2. Occurrence of Soft Tissue Damage-Related Diseases Diagnosed More Frequently in the Aging Population

2.7.3. Adverse Effects of Obesity on the Musculoskeletal System

2.8. Market Challenges

2.8.1. Indistinct Regulatory Environment

2.8.2. Unfavorable Reimbursement Hindering the Market Growth

2.9. Market Opportunities

2.9.1. Opportunities for the Soft Tissue Repair Market in Developing Economies

2.9.2. Demand for Soft Tissue Repair Products Catering to Sports-Related Injuries

3. Market by Product Type

4. Market by Application

5. Geographical Analysis - North America

6. Company Profile

7. Research Methodology & Scope

Companies Mentioned

• Allergan
• Athersys Inc
• Bard Peripheral Vascular Inc
• Baxter International Inc
• Becton Dickinson and Company (Bd)
• Boston Scientific Corporation
• Cryolife Inc
• Johnson & Johnson
• Integra Lifesciences Corporation
• Medtronic plc
• Organogenesis Inc
• Stryker Corporation
• Smith & Nephew plc
• Wl Gore and Associates
• Zimmer Biomet Inc

For more information about this report visit https://www.researchandmarkets.com/r/td96q8